Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 151–200 of 220 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03674411	Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy	active not recruiting	Phase 2	22	Masonic Cancer Center, University of MinnesotaOTHER	1	Jan 6, 2026	clinicaltrials
NCT06744075	Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma(CELERITY)	active not recruiting	N/A	108	Centre Henri BecquerelOTHER	1	Dec 30, 2025